Loncar China BioPharma (CHNA) ETF Holdings & Analysis
ETFOther
What CHNA does
The fund's advisor endeavors to allocate nearly all of its assets to the specific securities and depositary receipts comprising its benchmark index. This index is crafted to reflect the performance of a modified equal-weighted collection of Chinese companies, each playing a direct role in the expansion of China's pharmaceutical and biotechnology sectors.
Fund profile
Top holdings
| Holding | Weight | |
|---|---|---|
| 9939 | 4.42% | |
| 1548 | 3.88% | |
| 2196 | 3.25% | |
| 1093 | 3.00% | |
| 6185 | 2.57% | |
| 867 | 2.39% | |
| 3759 | 2.36% | |
| 9966 | 2.26% | |
| 2096 | 2.25% | |
| 460 | 2.24% |
Sector allocation
| Healthcare | 100.00% |
Geographic allocation
| United States | 5.60% |
| China | 5.61% |
| Hong Kong | 1.29% |
| Other | 87.50% |
PortView Portfolio Insights
PortView analyzes how CHNA fits your actual portfolio — position weight, ETF overlap with your other funds, sector and geographic exposure, concentration, and how this fund contributes to your portfolio risk and return. Connect a portfolio to see your personalized figures; PortView never shows another user's private holdings.
Analyze CHNA in PortView →Related securities
Related stocks
Frequently asked questions
- What does CHNA track?
- CHNA is the Loncar China BioPharma ETF, a Other ETF.
- What is the expense ratio of CHNA?
- Expense ratio data for CHNA is shown on the page when available from our data provider.
- What are the largest holdings in CHNA?
- Top holdings include 9939, 1548, 2196, 1093, 6185.
- How can PortView analyze CHNA overlap with other ETFs?
- PortView computes the holdings overlap between CHNA and the other ETFs and stocks you own, plus your combined sector and geographic exposure, so you can see true diversification.
The information provided by PortView is for informational and educational purposes only and does not constitute investment advice. Market data may be delayed. Past performance does not guarantee future results.